Similarly, ex vivo culture of mouse SCLC cells with increasing doses of etoposide generated resistant cells with upregulated YAP1 [23], and ex vivo cultures of two CDXs with high YAP1 from a biobank of 39 CDXs show resistance to cisplatin [25]. The gene discussed is YAP1; the disease is small cell lung carcinoma.